158 related articles for article (PubMed ID: 38367511)
1. New insights on neurodegeneration triggered by iron accumulation: Intersections with neutral lipid metabolism, ferroptosis, and motor impairment.
Maniscalchi A; Benzi Juncos ON; Conde MA; Funk MI; Fermento ME; Facchinetti MM; Curino AC; Uranga RM; Alza NP; Salvador GA
Redox Biol; 2024 May; 71():103074. PubMed ID: 38367511
[TBL] [Abstract][Full Text] [Related]
2. Silver nanoparticles induce iron accumulation-associated cognitive impairment via modulating neuronal ferroptosis.
Zhai X; Yan W; Liu S; Tian L; Zhang Y; Zhao Y; Ni Y; Shen H; Wang J; Wan Z; Jiang F; Xin L
Environ Pollut; 2024 Apr; 346():123555. PubMed ID: 38369090
[TBL] [Abstract][Full Text] [Related]
3. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
[TBL] [Abstract][Full Text] [Related]
4. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
5. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration.
Hambright WS; Fonseca RS; Chen L; Na R; Ran Q
Redox Biol; 2017 Aug; 12():8-17. PubMed ID: 28212525
[TBL] [Abstract][Full Text] [Related]
6. Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration.
Villalón-García I; Povea-Cabello S; Álvarez-Córdoba M; Talaverón-Rey M; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Reche-López D; Cilleros-Holgado P; Piñero-Pérez R; Sánchez-Alcázar JA
Neural Regen Res; 2023 Jun; 18(6):1196-1202. PubMed ID: 36453394
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
Sánchez Campos S; Alza NP; Salvador GA
Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of manganese via ferroptosis induced by redox imbalance and iron overload.
Wang C; Zhao H; Liu Y; Qu M; Lv S; He G; Liang H; Chen K; Yang L; He Y; Ou C
Ecotoxicol Environ Saf; 2024 Jun; 278():116404. PubMed ID: 38705038
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles.
Sánchez Campos S; Rodríguez Diez G; Oresti GM; Salvador GA
PLoS One; 2015; 10(6):e0130726. PubMed ID: 26076361
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis in Parkinson's disease: glia-neuron crosstalk.
Wang ZL; Yuan L; Li W; Li JY
Trends Mol Med; 2022 Apr; 28(4):258-269. PubMed ID: 35260343
[TBL] [Abstract][Full Text] [Related]
13. Iron chelation prevents nigrostriatal neurodegeneration in a chronic methamphetamine mice model.
Hu S; Huang X; Huang J; Qian Y; Tian Y; Xiao Y; Qi X; Zhou X; Yang Z; Chen Z
Neurotoxicology; 2023 Dec; 99():24-33. PubMed ID: 37717738
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Insights on Ferroptosis in Parkinson's disease.
Thapa K; Khan H; Kanojia N; Singh TG; Kaur A; Kaur G
Eur J Pharmacol; 2022 Sep; 930():175133. PubMed ID: 35792170
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in the motor cortex induces neuronal ferroptosis following spinal cord injury.
Feng Z; Min L; Chen H; Deng W; Tan M; Liu H; Hou J
Redox Biol; 2021 Jul; 43():101984. PubMed ID: 33933882
[TBL] [Abstract][Full Text] [Related]
16. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
[TBL] [Abstract][Full Text] [Related]
17. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
Cerasuolo M; Di Meo I; Auriemma MC; Trojsi F; Maiorino MI; Cirillo M; Esposito F; Polito R; Colangelo AM; Paolisso G; Papa M; Rizzo MR
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298586
[TBL] [Abstract][Full Text] [Related]
18. ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons.
Bouchaoui H; Mahoney-Sanchez L; Garçon G; Berdeaux O; Alleman LY; Devos D; Duce JA; Devedjian JC
Free Radic Biol Med; 2023 Feb; 195():145-157. PubMed ID: 36581060
[TBL] [Abstract][Full Text] [Related]
19. Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation.
Angelova PR; Choi ML; Berezhnov AV; Horrocks MH; Hughes CD; De S; Rodrigues M; Yapom R; Little D; Dolt KS; Kunath T; Devine MJ; Gissen P; Shchepinov MS; Sylantyev S; Pavlov EV; Klenerman D; Abramov AY; Gandhi S
Cell Death Differ; 2020 Oct; 27(10):2781-2796. PubMed ID: 32341450
[TBL] [Abstract][Full Text] [Related]
20. Modeling ferroptosis in human dopaminergic neurons: Pitfalls and opportunities for neurodegeneration research.
Renner N; Schöb F; Pape R; Suciu I; Spreng AS; Ückert AK; Cöllen E; Bovio F; Chilian B; Bauer J; Röpcke S; Bergemann J; Leist M; Schildknecht S
Redox Biol; 2024 Jul; 73():103165. PubMed ID: 38688061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
